Continuous Bioprocessing Market to Grow with a CAGR of 9.59% through 2029
Rising development in bioprocessing is expected to drive the
Global Continuous Bioprocessing Market in the forecast period 2025-2029
According to TechSci Research report, “Continuous
Bioprocessing Market– Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2029”, the Global Continuous Bioprocessing
Market stood at USD 231.23
million in 2023 and is anticipated to grow with a CAGR of 9.59% in the forecast
period, 2025-2029. The Global Continuous Bioprocessing Market has emerged as a
transformative force within the biopharmaceutical sector, challenging and
revolutionizing conventional batch processing methodologies. Continuous
bioprocessing stands out for its myriad advantages, bringing about increased
productivity, enhanced cost efficiency, and heightened flexibility in
manufacturing operations. This market's substantial growth is fueled by multiple
factors, including the ever-growing demand for biopharmaceuticals, continuous
advancements in bioprocessing technologies, and the imperative for more
streamlined and scalable production processes. A pivotal driver behind the
flourishing continuous bioprocessing market is the surge in chronic diseases
worldwide, contributing to an unprecedented demand for biopharmaceutical
products. The inherent capability of continuous bioprocessing to facilitate uninterrupted
and consistent production addresses the critical need for a reliable and
sustained supply of vital medications. Furthermore, the market is propelled by
a strategic focus on cost reduction in production. Continuous bioprocessing not
only ensures operational efficiency but also significantly cuts down on
production costs, serving as a fundamental incentive for companies aiming to
optimize their manufacturing processes and bolster overall cost-effectiveness. As
the industry grapples with the complexities of modern healthcare challenges,
continuous bioprocessing emerges as a solution that not only meets the
escalating demand for life-saving pharmaceuticals but also aligns with the
broader goals of efficiency, cost savings, and adaptability in the dynamic
landscape of biopharmaceutical manufacturing.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Continuous Bioprocessing Market”
The Global Continuous Bioprocessing Market is
segmented into product, process, application, end user, regional distribution, and
company.
Based on Product, the market is divided into upstream
and downstream. Downstream dominated the market in 2023.This is attributed due t0
critical role in refining and purifying biopharmaceutical products. Downstream
processing ensures the isolation and purification of the desired bioproducts
from the complex mixtures generated during upstream bioprocessing. This phase
significantly influences product quality and compliance with regulatory
standards. As continuous bioprocessing gains prominence, optimizing downstream
processes becomes imperative for efficient and cost-effective production. The
focus on improving purification techniques, increasing product yield, and
meeting stringent quality requirements positions the downstream segment as a
key driver of success in the continuous bioprocessing market.
Based on Application, the market is
divided into monoclonal antibodies, vaccines, cell and gene therapy, other.
Vaccines dominated the market in 2023.This is ascribed due their unparalleled
impact on public health. They prevent infectious diseases, saving lives and
reducing healthcare burdens. The ongoing global focus on disease prevention,
especially in the wake of the COVID-19 pandemic, has further underscored the
importance of vaccines. Additionally, robust vaccination programs, advancements
in vaccine technology, and regulatory support contribute to their market
dominance. The preventive nature of vaccines aligns with global health
strategies, making them a cornerstone in the fight against various infectious
diseases, ultimately fostering community well-being and resilience.
The increased demand for
biopharmaceuticals stands as a pivotal driver propelling the growth of the
Global Continuous Bioprocessing Market. With a surge in the incidence of
chronic diseases globally, there is a corresponding rise in the demand for
innovative and targeted biopharmaceutical therapies. Traditional batch
processing methods often face challenges in meeting the escalating demand due
to their inherent limitations, such as longer production times and lower
scalability. Continuous bioprocessing addresses these constraints by providing
a streamlined and uninterrupted production process, aligning seamlessly with
the pressing need for efficient and rapid manufacturing.
Major companies operating in Global Continuous
Bioprocessing Market are:
- Thermo Fisher
Scientific Inc.
- 3M Co.
- Merck & Co Inc
- Sartorius AG
- Eppendorf SE
- Corning Inc
- Meissner AG
- OmniBRx
Biotechnologies Pvt Ltd
- Bio-Rad
Laboratories Inc
- Fujifilm
Corporation
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The Global Continuous Bioprocessing Market is driven
by escalating demand for biopharmaceuticals, offering increased productivity,
cost efficiency, and manufacturing flexibility. Advances in bioprocessing
technologies, the prevalence of chronic diseases, and the imperative for
streamlined production processes propel market growth. The ability of
continuous bioprocessing to ensure consistent and uninterrupted production,
coupled with a focus on reducing production costs, serves as a catalyst.
Additionally, regulatory support and industry collaborations contribute to its
expansion, positioning continuous bioprocessing as a pivotal force in modern
biopharmaceutical manufacturing” said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based management consulting firm.
“Continuous Bioprocessing
Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029
Segmented By Product (Chromatography Systems and Consumables, Bioreactors,
Filtration Systems and Devices, Others), By Process (Downstream, Upstream), By Application
(Monoclonal Antibodies, Vaccines, Cell and Gene Therapy, Other), By End-User
(Pharmaceutical and Biopharmaceutical Companies, Contract Research
Organizations, Academic and Research Institutes, Others), By Region and
Competition”, has evaluated
the future growth potential of Global Continuous Bioprocessing Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Bioprocess Bags & Containers Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com